You are here

SARC006

Completed
Phase 2 Trial of Chemotherapy in Sporadic and Neurofibromatosis Type 1 Associated High Grade Malignant Peripheral Nerve Sheath Tumors
Type of Sarcoma: 
Malignant peripheral nerve sheath tumors sporadic or NF1 associated
Drug: 
Adriamycin/ifosfamide and Adriamycin/etoposide
Accrual Status: 
Closed
Co-Principal Investigators: 

Brigitte Widemann, MD
National Cancer Institute

For more information about this trial and open sites: